AET NOTICE: Rosen Law Firm Reminds Aetna Inc. Investors of

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
167
AET NOTICE: Rosen Law Firm Reminds Aetna Inc. Investors of Important Deadline in Class Action – AET

NEW YORK, March 02, 2017 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Aetna Inc. securities (NYSE: AET ) from August 15, 2016 through January 20, 2017, inclusive (the “Class Period”) of the important March 27, 2017 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Aetna investors under the federal securities laws.

To join the Aetna class action, go to http://rosenlegal.com/cases-1039.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or kchan@rosenlegal.com for information on the class action.

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.

According to the lawsuit, throughout the Class Period Defendants made false and/or misleading statements and/or failed to disclose that: (1) Aetna and its senior executives attempted to leverage Aetna’s participation in the Public Exchanges for favorable treatment from regulators regarding the Humana acquisition; (2) Aetna threatened to limit its participation in public health insurance exchanges if the Department of Justice (“DOJ”) attempted to block the merger; (3) Aetna did not withdraw from certain public health insurance exchanges for business reasons as Defendants claimed, but to follow through on its threat of leaving the marketplace once the DOJ filed suit and to improve its litigation position; (4) Aetna withdrew from public health insurance exchanges that were profitable for Aetna; and (5) as a result of the foregoing, Defendants’ statements about Aetna’s business, operations, and prospects were false and misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 27, 2017. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://rosenlegal.com/cases-1039.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. or Kevin Chan, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at pkim@rosenlegal.com or kchan@rosenlegal.com .

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm .

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. Kevin Chan, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 34th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 lrosen@rosenlegal.com pkim@rosenlegal.com kchan@rosenlegal.com www.rosenlegal.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Q32 Bio Eyes New Horizons with Bempikibart's Potentials

Updated Category News Views 69

Q32 Bio Steers Forward: New Insights from Chief Results Today's update isn't just another quarterly snooze-fest—it’s a nudge in a crucial direction for Q32 Bio (NASDAQ:QTTB). After a bold brush with the European Academy of Dermatology and Venereology (EADV) Congress 2026, the company laid out a plan and a half, showing its hand with bempikibart for alopecia areata...

Continue Reading
First Industrial Declares Regular Dividend Amid Growth Insights

Updated Category News Views 116

Dividend Declaration Reflects Confidence First Industrial Realty Trust, folks, just put another office stamp on their ongoing reliability quest—and I'm talking dividends. They're shelling out a tidy $0.50 per share for Q4 2026, with stockholders due to see the cash on January 19, 2027. That's like clockwork precision, showing a steadiness in what some call the unruly...

Continue Reading
Toufayan's Sourdough Pita: A Century-Old Recipe Revival

Updated Category News Views 23

Crafting Tradition in Modern Times Ever see a family business stick to its roots despite the whirlwind of fleeting trends? Step aside, because Toufayan isn’t just baking bread—they're pulling a Houdini act, bringing a recipe out of the past and into our grocery aisles. By launching their Simply Sourdough pita, these folks are banking on good ol’ nostalgia and...

Continue Reading
Japan's RWE Market Transformation: TXP's Insightful Whitepaper

Updated Category News Views 55

Unraveling the Real-World Evidence Landscape in Japan The folks at TXP Medical just dropped a bombshell of a whitepaper that'll have Medical Affairs departments buzzing. Imagine waking up to a market that's exploding by over 500% in just a decade—yeah, I'm talking about the EMR-derived data market in Japan. These guys are saying it's gonna shoot from ¥3.9 billion in...

Continue Reading
Askey & Icom Team Up: Trading Airwaves for Partnerships

Updated Category News Views 28

Old-School Radios Meet Cutting-Edge 5G When I hear about a company linking their old-school tech with shiny new 5G jazz, skepticism kicks in fast. But then comes this announcement: Askey and Icom America are joining forces to bring 5G networks with integrated two-way radio systems to various sectors—like a classic combo meal with a tech twist. The key audience? Utility...

Continue Reading
Acuity Analytics Charts Ambitious AI-Driven Future

Updated Category News Views 128

The New Era at Acuity Analytics Has Begun Isn't it something when a company decides to shake things up in such a daring way? Acuity Analytics just gave the financial sector a reason to sit up and pay attention. They've brought in Jon O'Donnell as the new Chief Executive Officer, a move that's got the city talking. O'Donnell is no rookie; he's a former IBM heavyweight and...

Continue Reading
A Journey Through Mongolia's Wilderness and Self-Discovery

Updated Category News Views 57

A Late-Life Adventure Without Borders We all hit that age where adventure seems just a memory—until something shakes us from our slumber, just like Betsy Cooksey’s wild ride into Mongolia. At an age when most tether their dreams to sunlit porches and grandkids' photos, Cooksey grabbed life by the reins. First, though, we gotta talk about the absolute gamble she took....

Continue Reading
Lone Star's Debrief IQ: Revamping Military Training

Updated Category News Views 20

A Milestone for Military Pilot Training In the grand scheme of military pilot training, Debrief IQ from Lone Star Analysis is making waves. Apparently, they're shaving off a hefty 35 minutes of the grind instructors typically endure post-training sessions. I bet the flight schools are letting out a collective sigh of relief. Years of Frustration Handled by AI So, what's...

Continue Reading
Tigo Energy Faces Legal Heat Over Fraud Allegations

Updated Category News Views 142

Tigo Energy's Legal Battle Heats Up If you haven't been paying attention, it’s time to get your eyes on Tigo Energy (NASDAQ: TYGO). The company is now in the hot seat with a securities fraud lawsuit that's got investors on edge. This isn’t just a minor squabble; we're talking about allegations that could shake the ground beneath its share price. The Claims and...

Continue Reading
AI Shift: From Tech Marvels to Practical Uses

Updated Category News Views 80

A New Chapter in the AI Narrative Take a seat, folks, because we're watching AI swing from showy tech to something as plain as plumbing infrastructure. Imagine models that once cost bundles per token now going for peanuts. We're talking a nosedive from $37.50 to a mere 18 cents. It’s a seismic shift, steering the conversation from 'Are they the best models?' to 'How...

Continue Reading

Top 5 Most Recently Viewed Articles

Angel Oak Financial Strategies Hits New High of $13.35

Updated Category News Views 193

Angel Oak Financial Strategies Reaches New Heights Shares of Angel Oak Financial Strategies (FINS) have achieved a remarkable milestone by reaching a 52-week high, trading at an impressive $13.35. This significant growth is a testament to the company’s strong performance in the financial market. Investors are celebrating as they witness this increase, which stands as a...

Continue Reading
Indonesian Market Update: IDX Composite Index Drop Analyzed

Updated Category News Views 263

Overview of the Indonesian Stock Market's Recent Performance On a recent trading day, the Indonesian stock market experienced a notable decline, with the IDX Composite Index sliding 1.08%. This downtrend was largely influenced by losses in significant sectors such as Financials, Infrastructure, and Agriculture. Understanding these dynamics is essential for investors and...

Continue Reading
Eagle Bancorp Teams Up for Major Financial Conference in November

Updated Category News Views 103

Eagle Bancorp to Feature at Notable Financial Conference Eagle Bancorp, Inc. (NASDAQ: EGBN), the prominent holding company of EagleBank, is gearing up to participate in an influential financial event. This conference, the Piper Sandler East Coast Financial Services Conference, takes place over several days, offering a platform for significant discussions within the...

Continue Reading
Breathe Drops: A Game-Changer for Respiratory Wellness

Updated Category News Views 295

Introducing Breathe Drops: A Revolutionary Wellness Solution In the ever-evolving world of wellness, Breathe is thrilled to unveil its latest product, Breathe Drops. This unique formula aims to enhance lung health and respiratory wellness by harnessing the power of carefully selected natural ingredients. Designed for individuals seeking natural wellness solutions, Breathe...

Continue Reading
Keros Therapeutics to Showcase Innovations at Health Conference

Updated Category News Views 132

Keros Therapeutics to Showcase Innovations at Health Conference During an important upcoming event, Keros Therapeutics, Inc. (NASDAQ: KROS), a clinical-stage biopharmaceutical company, will highlight its ongoing commitment to developing novel therapeutics aimed at treating conditions tied to dysfunctional signaling of the transforming growth factor-beta (TGF-ß) protein...

Continue Reading